deferiprone has been researched along with trolamine salicylate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
al-Refaie, FN; Hershko, C; Hoffbrand, AV; Kosaryan, M; Olivieri, NF; Tondury, P; Wonke, B | 1 |
Castriota-Scanderbeg, A; Sacco, M | 1 |
Perifanis, V; Tsatra, I; Tsayas, I; Tselios, K; Vlachaki, E | 1 |
Berjawi, A; Haydar, AA; Khamashta, MA; Noureldine, MHA; Taher, AT; Uthman, I | 1 |
2 review(s) available for deferiprone and trolamine salicylate
Article | Year |
---|---|
Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature.
Topics: Adult; Arthritis; beta-Thalassemia; Deferiprone; Humans; Iron Chelating Agents; Knee Joint; Male; Pyridones | 2008 |
Rheumatological complications of beta-thalassaemia: an overview.
Topics: Arthritis; beta-Thalassemia; Blood Transfusion; Connective Tissue Diseases; Deferiprone; Femur Head Necrosis; Fractures, Bone; Humans; Iron Chelating Agents; Iron Overload; Joint Diseases; Myalgia; Osteoporosis; Pseudoxanthoma Elasticum; Pyridones; Transfusion Reaction | 2018 |
2 other study(ies) available for deferiprone and trolamine salicylate
Article | Year |
---|---|
Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators.
Topics: Adult; Agranulocytosis; Arthritis; beta-Thalassemia; Chemical and Drug Induced Liver Injury; Deferiprone; Drug Administration Schedule; Female; Follow-Up Studies; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Male; Pyridones | 1995 |
Agranulocytosis, arthritis and systemic vasculitis in a patient receiving the oral iron chelator L1 (deferiprone).
Topics: Adult; Agranulocytosis; Arthritis; beta-Thalassemia; Deferiprone; Female; Humans; Pyridones; Vasculitis | 1997 |